Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03499067 · ClinicalTrials.gov registry record

A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens

A clinical trial of Myopia, sponsored by CooperVision.

Completed
Registry status
58
Enrollment target
2
Study locations

NCT03499067 is a study of Myopia that has completed, run by CooperVision. The registered enrollment target is 58 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03499067, a study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
58 participants
Enrollment target
2
Study locations

Study Summary

Evaluation of the clinical performance of an investigational silicone-hydrogel contact lens (test) compared to a marketed lens (control), when worn on a daily basis for 1 month.

Conditions Studied

Myopia

Interventions

  • DEVICE Test lens
  • DEVICE Control lens

Study Locations (2)

California

  • Clinical Research Center, University of California, Berkeley - Berkeley

Indiana

  • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2018-04-11
Est. Completion 2018-08-01

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03499067

The ClinicalTrials.gov registry entry for NCT03499067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (78% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test lens is the first listed.

NCT03499067 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Indiana.

Frequently Asked Questions

What is clinical trial NCT03499067 about?

NCT03499067 is a clinical study titled "A Dispensing Clinical Trial of Test Contact Lens Against Marketed Contact Lens". Evaluation of the clinical performance of an investigational silicone-hydrogel contact lens (test) compared to a marketed lens (control), when worn on a daily basis for 1 month.

What is the current status of trial NCT03499067?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2018-04-11. Estimated completion is 2018-08-01.

What conditions does trial NCT03499067 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT03499067?

The interventions under investigation include: Test lens (DEVICE), Control lens (DEVICE).

Who is sponsoring clinical trial NCT03499067?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03499067 being conducted?

This trial has 2 study locations across California, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.